Leveraging the gut immune system to deliver precision cytotoxic immunotherapies

Our approach combines the convenience of oral administration with the power of a targeted, systemic T-cell response

MORE

New Class of Cytotoxic Immunotherapies

Learn more about VAXIMM technology

Robust Development Pipeline to Address Clinically-Validated Targets with Novel Immunotherapies

Learn more about our pipeline

Corporate Vision and Mission Scientifically Grounded by Founding Leadership

Learn more about us